Mortality among critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia: A multicenter cohort study in Colombia

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 32, Issue 5, 2012, Pages 343-350

  Castillo Londoño, Juan S ^a   Leal, Aura L ^a   Cortes, Jorge A ^a   Alvarez, Carlos A ^a   Sanchez, Ricardo ^a   Buitrago, Giancarlo ^a   Barrero, Liliana I ^a   Gonzalez, Andrés L ^a   Henriquez, Daibeth H ^b  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b Secretaria Distrital de Salud   (Colombia)

Author keywords

Bacterial infections; Colombia; Methicillin resistant Staphylococcus aureus; Mortality; Outcome assessment (health care); Risk factors

Indexed keywords

ANTIBIOTICS; ANTIMICROBIAL ACTIVITY; BACTERIUM; COHORT ANALYSIS; DISEASE CONTROL; EMERGENCE; EPIDEMIOLOGY; HEALTH CARE; MORTALITY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; COHORT ANALYSIS; COLOMBIA; CRITICAL ILLNESS; FEMALE; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; RETROSPECTIVE STUDY; STAPHYLOCOCCUS INFECTION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BACTEREMIA; COHORT STUDIES; COLOMBIA; CRITICAL ILLNESS; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

COLOMBIA;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 84872898910     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892012001100004     Document Type: Article

References (41)

1. Peacock JE Jr, Marsik FJ, Wenzel RP. Methicillinresistant Staphylococcus aureus: introduction and spread within a hospital. Ann Intern Med. 1980;93: 526-32. (Pubitemid 10015172)
2. Espinosa CJ, Cortés JA, Castillo JS, Leal AL. Systematic review of antimicrobial resistance among Gram positive cocci in hospitals in Colombia. Biomedica. 2011;31: 27-34.
3. van Duijn PJ, Dautzenberg MJ, Oostdijk EA. Recent trends in antibiotic resistance in European ICUs. Curr Opin Crit Care. 2011;17: 658-65.
4. Leal AL, Eslava-Schmalbach J, Alvarez C, Buitrago G, Méndez M; Grupo para el Control de la Resistencia Bacteriana en Bogotá. Endemic tendencies and bacterial resistance markers in third-level hospitals in Bogotá, Colombia. Rev Salud Publica (Bogota). 2006;8 suppl 1;59-70. (Pubitemid 44238698)
5. Shorr AF. Epidemiology and economic impact of meticillin-resistant Staphylococcus aureus: review and analysis of the literature. Pharmacoeconomics. 2007;25: 751-68. (Pubitemid 47481640)
6. Harbarth S, Rutschmann O, Sudre P, Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med. 1998;158: 182-9. (Pubitemid 28049512)
7. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin- resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36: 53-9. (Pubitemid 36099097)
8. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005;26: 166-74. (Pubitemid 40445022)
9. Rubio-Terrés C, Garau J, Grau S, Martinez- Martinez L, Cast of Resistance Study group. Cost of bacteraemia caused by methicillinresistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study. Clin Microbiol Infect 2010;16: 722-8.
10. van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus Bacteremia. Clin Microbiol Rev. 2012;25: 362-86.
11. Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, et al.; Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study Group. Clinical impact of methicillin resistance on outcome of patients with Staphylococcus aureus infection: a stratified analysis according to underlying diseases and sites of infection in a large prospective cohort. J Infect. 2010;61: 299-306.
12. Rello J, Ricart M, Mirelis B, Quintana E, Gurgui M, Net A, et al. Nosocomial bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes. Intensive Care Med. 1994;20: 94-8. (Pubitemid 24120269)
13. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin- resistant Staphylococcus aureus. Arch Intern Med. 2002;162: 2229-35. (Pubitemid 35231593)
14. Harbarth S, Ferrière K, Hugonnet S, Ricou B, Suter P, Pittet D. Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care. Arch Surg. 2002;137: 1353-9. (Pubitemid 35429592)
15. Thompson DS. Methicillin-resistant Staphylococcus aureus in a general intensive care unit. J R Soc Med. 2004;97: 521-6. (Pubitemid 39524202)
16. Gastmeier P, Sohr D, Geffers C, Behnke M, Daschner F, Rüden H. Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection Surveillance System (KISS). Infection. 2005;33: 50-5. (Pubitemid 40590991)
17. Oztoprak N, Cevik MA, Akinci E, Korkmaz M, Erbay A, Eren SS, et al. Risk factors for ICU-acquired methicillin-resistant Staphylococcus aureus infections. Am J Infect Control. 2006;34: 1-5. (Pubitemid 43144348)
18. Thompson DS, Workman R, Strutt M. Contribution of acquired meticillin-resistant Staphylococcus aureus bacteraemia to overall mortality in a general intensive care unit. J Hosp Infect. 2008;70: 223-7.
19. Ho KM, Robinson JO. Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study. Anaesth Intensive Care. 2009;37: 457-63.
20. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118: 146-55. (Pubitemid 30485502)
21. Schramm GE, Johnson JA, Doherty JA, Micek ST, Kollef MH. Methicillin-resistant Staphylococcus aureus sterile-site infection: The importance of appropriate initial antimicrobial treatment. Crit Care Med. 2006;34: 2069-74. (Pubitemid 44305607)
22. Cortés JA, Garzón DC, Navarrete JA, Contreras KM. Impact of inappropriate antimicrobial therapy on patients with bacteremia in intensive care units and resistance patterns in Latin America. Rev Argent Microbiol. 2010;42: 230-4.
23. Horan TC, Andrus M, Dudeck MA. CDC/ NHSN surveillance definition of health careassociated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36: 309-32. (Pubitemid 351763841)
24. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137: 791-7. (Pubitemid 35334450)
25. Carmeli Y, Troillet N, Karchmer AW, Samore MH. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med. 1999;159: 1127-32. (Pubitemid 29230866)
26. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13: 818-29. (Pubitemid 15250137)
27. Craven DE, Kunches LM, Lichtenberg DA, Kollisch NR, Barry MA, Heeren TC, McCabe WR. Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch Intern Med. 1988. May;148(5): 1161-8.
28. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40: 373-83. (Pubitemid 17055592)
29. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al.; SCCM/ESICM/ ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31: 1250-6. (Pubitemid 36444440)
30. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 19th informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2009.
31. Rabe-Hesketh S. A handbook of statistical analyses using Stata. Third ed. Boca Raton: CRC Press; 2004.
32. Gastmeier P, Sohr D, Geffers C, Behnke M, Rüden H. Risk factors for death due to nosocomial infection in intensive care unit patients: findings from the Krankenhaus Infections Surveillance System. Infect Control Hosp Epidemiol. 2007;28: 466-72. (Pubitemid 46658061)
33. Ammerlaan H, Seifert H, Harbarth S, Brun- Buisson C, Torres A, Antonelli M, et al.; European Practices of Infections with Staphylococcus aureus (SEPIA) Study Group. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries. Clin Infect Dis. 2009;49: 997-1005.
34. Marchaim D, Kaye KS, Fowler VG, Anderson DJ, Chawla V, Golan Y, et al. Case-control study to identify factors associated with mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2010;16: 747-52.
35. Alvarez Lerma F, Palomar M, Insausti J, Olaechea P, Cerdá E, Sánchez Godoy J, et al.; Grupo de Estudio Nacional de Vigilancia de Infección Nosocomial en UCI. Infecciones nosocomiales por Staphylococcus aureus en pacientes críticos en unidades de cuidados intensivos. Med Clin (Barc). 2006;126: 641-6. (Pubitemid 43886684)
36. Wang FD, Chen YY, Chen TL, Lin YT, Fung CP. Risk factors and mortality of nosocomial infections of methicillin-resistant Staphylococcus aureus in an intensive care unit. J Crit Care. 2011;26: 82-8.
37. Alberti C, Brun-Buisson C, Goodman SV, Guidici D, Granton J, Moreno R, et al. European Sepsis Group. Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med. 2003;168: 77-84. (Pubitemid 37046636)
38. Combes A, Luyt CE, Trouillet JL, Nieszkowska A, Chastre J. Gender impact on the outcomes of critically ill patients with nosocomial infections. Crit Care Med. 2009;37: 2506-11.
39. Moreno CA, Rosenthal VD, Olarte N, Gomez WV, Sussmann O, Agudelo JG, et al. Deviceassociated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium. Infect Control Hosp Epidemiol. 2006;27: 349-56. (Pubitemid 43736098)
40. Alvarez CA, Yomayusa N, Leal AL, Moreno J, Mendez-Alvarez S, Ibañez M, et al. Nosocomial infections caused by community-associated methicillin-resistant Staphylococcus aureus in Colombia. Am J Infect Control. 2010;38: 315-8.
41. Rodríguez-Noriega E, Seas C, Guzmán- Blanco M, Mejía C, Alvarez C, Bavestrello L, et al. Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America. Int J Infect Dis. 2010;14:e560-6.